Page last updated: 2024-11-02

oxophenylarsine and Pulmonary Edema

oxophenylarsine has been researched along with Pulmonary Edema in 1 studies

oxophenylarsine: inhibits protein-tyrosine-phosphatase
phenylarsine oxide : An arsine oxide derived from phenylarsine.

Pulmonary Edema: Excessive accumulation of extravascular fluid in the lung, an indication of a serious underlying disease or disorder. Pulmonary edema prevents efficient PULMONARY GAS EXCHANGE in the PULMONARY ALVEOLI, and can be life-threatening.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Roussin, A1
Le Cabec, V1
Lonchampt, M1
De Nadaï, J1
Canet, E1
Maridonneau-Parini, I1

Other Studies

1 other study available for oxophenylarsine and Pulmonary Edema

ArticleYear
Neutrophil-associated inflammatory responses in rats are inhibited by phenylarsine oxide.
    European journal of pharmacology, 1997, Mar-12, Volume: 322, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arsenicals; Bronchoalveolar Lavage Fluid; Carragee

1997